Precision Psychiatry Market Insights Highlighting Growth Opportunities

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Precision Psychiatry Market In 2026, And How Will Its Value Evolve By 2030?

The precision psychiatry market has experienced rapid growth in recent years. It is forecast to increase from $4.99 billion in 2025 to $5.72 billion in 2026, at a compound annual growth rate (CAGR) of 14.7%. Historically, this expansion has been driven by the increasing prevalence of mental health disorders, the growing challenges of trial-and-error prescribing, the expansion of psychiatric research initiatives, the rising availability of neuroimaging technologies, and the early adoption of pharmacogenomics in psychiatry.

The precision psychiatry market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach a size of $9.81 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.4%. This expansion during the projection period stems from escalating investments in precision medicine platforms, the increasing uptake of AI-enabled diagnostic tools, the broadening of digital mental health solutions, a rising need for individualized psychiatric care, and a heightened emphasis on preventive mental health approaches. Key developments anticipated during this timeframe involve a greater embrace of biomarker-guided treatment routes, the expanded utilization of digital phenotyping tools, enhanced incorporation of genetic and neuroimaging information, the proliferation of AI-powered clinical decision support, and a sharpened focus on tailored mental health surveillance.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30359&type=smp

What Significant Factors Are Influencing The Precision Psychiatry Market Expansion?

The rising incidence of mental health disorders is projected to fuel the expansion of the precision psychiatry market moving forward. Mental health disorders cover a broad spectrum of conditions, including depression, anxiety, and bipolar disorder, which influence mood, thinking, and behavior. These disorders are becoming more common as a greater number of individuals encounter psychological distress due to social, economic, and environmental pressures, alongside improved screening methods and increased public awareness that contribute to higher diagnosis rates. Precision psychiatry addresses mental health disorders through the implementation of data-driven, customized treatment plans that enhance the accuracy of diagnosis and therapeutic results. For example, in November 2023, according to NHS England, the UK-based publicly funded national health authority, the percentage of individuals aged 20 to 23 years with a probable mental disorder rose from 18.7% in 2022 to 21.6% in 2023. Therefore, the increasing prevalence of mental health disorders is boosting the growth of the precision psychiatry market.

How Is The Precision Psychiatry Market Broken Down By Segment Categories?

The precision psychiatry market covered in this report is segmented –

1) By Therapeutic Approaches: Pharmacotherapy, Psychotherapy, Neurostimulation, Digital Therapeutics, Combination Therapies

2) By Technology: Genetic Testing, Biomarker Analysis, Brain Imaging Techniques, Wearable Devices, Artificial Intelligence And Machine Learning Solutions

3) By Disorders: Depression, Anxiety Disorders, Bipolar Disorder, Schizophrenia, Post-Traumatic Stress Disorder (PTSD)

4) By Application: Diagnosis, Treatment, Research

5) By End User: Clinics, Hospitals, Research Institutes, Pharmaceutical Companies, Home Care Settings

Subsegments:

1) By Pharmacotherapy: Antidepressant Medications, Antipsychotic Medications, Mood Stabilizers, Anxiolytic Medications, Stimulant Medications

2) By Psychotherapy: Cognitive Behavioral Therapy, Interpersonal Therapy, Psychodynamic Therapy, Dialectical Behavior Therapy, Mindfulness-Based Therapy

3) By Neurostimulation: Transcranial Magnetic Stimulation, Electroconvulsive Therapy, Vagus Nerve Stimulation, Deep Brain Stimulation, Transcranial Direct Current Stimulation

4) By Digital Therapeutics: Mobile Application-Based Therapy, Virtual Reality Therapy, Web-Based Cognitive Behavioral Programs, Remote Patient Monitoring Tools, Artificial Intelligence-Guided Interventions

5) By Combination Therapies: Pharmacotherapy And Psychotherapy Combination, Pharmacotherapy And Neurostimulation Combination, Pharmacotherapy And Digital Therapeutics Combination, Psychotherapy And Neurostimulation Combination, Multimodal Precision Treatment Programs

What Trends Are Affecting The Direction Of The Precision Psychiatry Market?

Key companies within the precision psychiatry market are concentrating their efforts on creating novel therapies, including prescription digital therapeutics, to facilitate individualized and data-informed treatment approaches for psychiatric conditions. A prescription digital therapeutic is defined as a software-driven medical intervention, prescribed by clinicians, which provides evidence-backed behavioral therapy modules via mobile devices, aiming to improve symptoms and increase adherence to treatment. Illustratively, in August 2024, Otsuka Precision Health Inc., a US-based precision health arm of Otsuka Holdings, collaborated with Click Therapeutics Inc., a US-based digital therapeutics firm, to introduce Rejoyn. This product stands as the singular prescription digital therapeutic to receive clearance from the United States Food and Drug Administration (FDA) for use as an add-on treatment for symptoms associated with major depressive disorder (MDD). This product offers a six-week cognitive-emotional training program, which integrates an emotional faces memory task with skill modules founded on cognitive behavioral therapy (CBT), while also facilitating digital prescriptions, patient involvement, and remote oversight. The introduction of Rejoyn marks a crucial achievement in Precision Psychiatry, showcasing the potential of digital therapeutics to augment pharmacological interventions in providing tailored patient care. Furthermore, it sets a precedent for wider acceptance of software-based interventions that incorporate real-time patient data to optimize both treatment results and adherence.

Which Players Are Present In The Precision Psychiatry Market Space?

Major companies operating in the precision psychiatry market are Johnson & Johnson, F. Hoffmann-La Roche Ltd, Pfizer Inc., AbbVie Inc., AstraZeneca plc, Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Otsuka Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Illumina Inc., ARUP Laboratories Inc., Sumitomo Dainippon Pharma Company Limited, QIAGEN N.V., Neurocrine Biosciences Inc., Tempus Labs Inc., Myriad Genetics Inc., MedGenome Labs Ltd., Genomind Inc.

Get The Full Precision Psychiatry Market Report:

https://www.thebusinessresearchcompany.com/report/global-precision-psychiatry-market-report

Where Is The Precision Psychiatry Market Most Concentrated Geographically?

North America was the largest region in the precision psychiatry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision psychiatry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Precision Psychiatry Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/global-precision-psychiatry-market-report

Browse Through More Reports Similar to the Global Precision Psychiatry Market 2026, By The Business Research Company

Syndicated Loans Market Report 2026

https://www.thebusinessresearchcompany.com/report/syndicated-loans-global-market-report

Revenue Based Financing Market Report

https://www.thebusinessresearchcompany.com/report/revenue-based-financing-global-market-report

Debt Financing Market Report

https://www.thebusinessresearchcompany.com/report/debt-financing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795